Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G7PB
|
||||
Former ID |
DNC006173
|
||||
Drug Name |
N-methyl-N-ethyl estradiol-16-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C22H31NO3
|
||||
Canonical SMILES |
CCN(C)C(=O)C1CC2C3CCC4=C(C3CCC2(C1O)C)C=CC(=C4)O
|
||||
InChI |
1S/C22H31NO3/c1-4-23(3)21(26)18-12-19-17-7-5-13-11-14(24)6-8-15(13)16(17)9-10-22(19,2)20(18)25/h6,8,11,16-20,24-25H,4-5,7,9-10,12H2,1-3H3/t16?,17?,18?,19?,20-,22-/m0/s1
|
||||
InChIKey |
UVOQIEBXUFHOKA-GFEBWMDQSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estradiol 17 beta-dehydrogenase 1 | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Superpathway of steroid hormone biosynthesis | ||||
Estradiol biosynthesis I | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolic pathways | |||||
Ovarian steroidogenesis | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | The canonical retinoid cycle in rods (twilight vision) | ||||
WikiPathways | Steroid Biosynthesis | ||||
Metabolism of steroid hormones and vitamin D | |||||
Prostate Cancer | |||||
References | |||||
REF 1 | J Med Chem. 2006 Feb 23;49(4):1325-45.Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.